Resources

Preclinical

The Power of Noninvasive Optical Imaging in Oncology Drug Development

December 7, 2020
Read Now
 
TD2 Blog TD2 Blog

White Papers

Clinical

Data Insights: Identifying Early Signs of Safety and Efficacy in Oncology Clinical Trials

The pharmaceutical industry, clinical teams and CROs rely on expert data analyses to ensure the safety and efficacy of investigational products. Recent advancements in data analytics use innovative collection methods, data environments and algorithms to transform complex, diverse datasets into creative insights for clinical trial use.

Read Download White Paper
Clinical

Technology and Next-Generation Oncology Trials

While cancer drug trials have seen many changes recently, one thing is certain – technology innovations are emerging as key components of any trial. CROs leverage different technological tools that improve patient recruitment, digital engagement, compliance, integration of disparate data sources, and data analytics.

Read Download White Paper
Clinical

The Trends Behind Successful Cancer Treatments

The approval and success of powerful new cancer treatments such as CAR T-cell therapy are breeding optimism among companies, scientists and patients around the world.TD2 can help influence your trial design and get your drug on a faster path to approval.

Read Download White Paper
Bioanalytical

The A-Z Guide of DMPK Assays and How to Find the Right One

You might know you need to conduct drug metabolism and pharmacokinetic (DMPK) analysis, but which tests are right for your project? And are you doing them at the right time? When building your preclinical strategy, these questions matter—and that’s true now more than ever, as new drug classes and targets emerge.

Read Download White Paper
Preclinical

6 Signs You Need a New CRO for Your Preclinical Research

You have goals for every project, and your CRO should be as committed to those goals as you are. But if things take too long to get done,it might be time to switch CROs instead. Learn to spot these six signs your preclinical work needs a new CRO.

Read Download White Paper
Clinical

The Quick-Start Guide to Clinical Strategy

Drug research has advanced in remarkable ways, but it’s still about the basics: ensuring safety, efficacy and compliance. That trio is no easy feat, but without a strong clinical strategy, even the most promising, safe and compliant drug can fail. Get your research in better strategic shape with this quick-start plan.

Read Download White Paper
Recent Blog Posts
Get free tips, tools and resources by subscribing to the TD2 Newsletter: